4-Octyl Itaconate Alleviates Myocardial Ischemia-Reperfusion Injury Through Promoting Angiogenesis via ERK Signaling Activation
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is being conducted on the mechanisms and potential treatments for myocardial ischemia-reperfusion injury. Some studies suggest that certain compounds, such as 4-octyl itaconate, may alleviate this type of injury by promoting angiogenesis through various signaling pathways. The role of macrophages and their metabolism in this process is also being explored, with potential therapeutic implications for cardiovascular disease.
Full coverage
12345